Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway

Journal of Clinical Oncology - United States
doi 10.1200/jco.2008.21.5988
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Pancreatic Endocrine Tumors

Modern Pathology
Forensic MedicinePathology
2011English

Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors

Clinical Cancer Research
Cancer ResearchOncology
2019English

The Expression of the PI3K/AKT/mTOR Pathway in Gastric Cancer and Its Role in Gastric Cancer Prognosis

OncoTargets and Therapy
OncologyPharmacology
2015English

Novel Expression Patterns of PI3K/Akt/mTOR Signaling Pathway Components in Colorectal Cancer

Journal of the American College of Surgeons
Surgery
2010English

Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway

Surgical Oncology Clinics of North America
SurgeryOncology
2013English

A Case of a Small Pancreatic Carcinoma With Endocrine Tumors

Suizo
2011English

Molecular Markers for Novel Therapeutic Strategies in Pancreatic Endocrine Tumors

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2013English

Targeting the Akt/mTOR Pathway in Brca1-Deficient Cancers

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy